Kathrin Strasser‐Weippl

Author

Wilhelminen Hospital ORCID

Also Known As

K Strasser-Weippl, K. Strasser-Weippl, Kathrin Strasser-Weippl, Kathrin Strasser‐Weippl

Publications

Citations

H-Index

Concepts

All Affiliations

Wilhelminen Hospital Massachusetts General Hospital Harvard University Queen's University University of Toronto

About

Kathrin Strasser‐Weippl is an author at Wilhelminen Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.6K
2	Public Health	4	4	1.1K
3	Health Sciences	3	3	87
4	Biostatistics	1	1	24
5	Cell Biology	1	1	44

Kathrin Strasser‐Weippl

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, New England Journal of Medicine	2016	633
Challenges to effective cancer control in China, India, and Russia Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky, The Lancet Oncology MedicineGlobal HealthCancer ManagementCancer PreventionBreast Cancer	2014	497
Planning cancer control in Latin America and the Caribbean Paul E. Goss, Brittany Lee, Tanja Badovinac-Črnjević, The Lancet Oncology Preventive MedicineMedicineGlobal HealthEpidemiology Of CancerCancer Prevention	2013	496
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Annals of Oncology Breast OncologyOverall SurvivalMedicinePathologyGermline Pathogenic Variants	2022	404
Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer Lilian U. Thompson, Jianmin Chen, Tong Li, Clinical Cancer Research	2005	256
Prevention Strategies with Aromatase Inhibitors Paul E. Goss, Kathrin Strasser‐Weippl Clinical Cancer Research	2004	58
Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma Kathrin Strasser‐Weippl, Heinz Ludwig European Journal Of Haematology Hematological MalignancyQuality Of LifeOncologyPsychiatryOutcomes Research	2008	55
Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor Michael Steurer, Heinz Zoller, Florian Augustin, Human Pathology InflammationProminent Angiogenic FactorFibrosisAngiogenesisHematology	2007	44
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy Kathrin Strasser‐Weippl, Nora Horick, Ian E. Smith, Breast Cancer Research	2015	36
Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis Kathrin Strasser‐Weippl, Ritesh Ramchandani, Lei Fan, Breast Cancer Research and Treatment Pregnancy-associated Breast CancerBreast OncologyCancer RiskCancer EpidemiologyMedicine	2014	33

Page 1